» Articles » PMID: 34889712

Long Non-coding RNA NHEG1/hsa-miR-665/HMGB1 Axis is Involved in the Regulation of Neuroblastoma Progression

Overview
Journal Bioengineered
Date 2021 Dec 10
PMID 34889712
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Long non-coding (lncRNA) neuroblastoma highly expressed 1 (NHEG1) has been reorganized as a prognostic factor in neuroblastoma (NB), but the molecular mechanisms in the suppression of neuroblastoma remain to be elucidated. In our study, we explored the functional roles of lncRNA NHEG1 in neuroblastoma and the underlying molecular mechanism. We collected NB tumor samples and adjacent normal tissues to compare lncRNA NHEG1 expression. Through bioinformatic target prediction, we selected potential downstream effectors of lncRNA NHEG1 for functional validation in NB cell lines. We observed that lncRNA NHEG1 was significantly upregulated in NB tissues as compared to the normal tissues. In NB tissues, lncRNA NHEG1 expression showed an inverse correlation with hsa-miR-665 (miR-655), but a positive correlation with high mobility group box 1 (HMGB1). In NB cell lines, lncRNA NHEG1 knockdown caused the upregulation of miR-665 and the downregulation of HMGB1. Through a series of functional assays, we further demonstrated that lncRNA Nheg1 knockdown suppressed cell proliferation, migration and invasion of NB cells, which could be rescued by miR-665 inhibitor and HMGB1 overexpression. Together, our data demonstrated that lncRNA NHEG1 serves as a competitive partner to negatively regulate the activity of miR-665, which relieves the inhibition on HMGB1 expression and promotes the aggressive phenotype of neuroblastoma cells. Our study indicates that lncRNA NHEG1/miR-665/HMGB1 axis may play an important role in regulating the aggressiveness and the progression of neuroblastoma.

Citing Articles

Gene, Protein, and in Silico Analyses of FoxO, an Evolutionary Conserved Transcription Factor in the Sea Urchin .

Russo R, Ragusa M, Arancio W, Zito F Genes (Basel). 2024; 15(8).

PMID: 39202438 PMC: 11353378. DOI: 10.3390/genes15081078.


Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets.

Vercouillie N, Ren Z, Terras E, Lammens T Int J Mol Sci. 2024; 25(11).

PMID: 38891878 PMC: 11171840. DOI: 10.3390/ijms25115690.


Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis.

Guan X, Pavani K, Chunduru J, Broeckx B, Van Soom A, Peelman L Cancers (Basel). 2023; 15(20).

PMID: 37894282 PMC: 10605552. DOI: 10.3390/cancers15204915.


Roles of lncRNAs in childhood cancer: Current landscape and future perspectives.

Liu F, Xiong Q, Wang J, Peng W Front Oncol. 2023; 13:1060107.

PMID: 36923440 PMC: 10008945. DOI: 10.3389/fonc.2023.1060107.


MicroRNAs and Gene Regulatory Networks Related to Cleft Lip and Palate.

Iwaya C, Suzuki A, Iwata J Int J Mol Sci. 2023; 24(4).

PMID: 36834963 PMC: 9958963. DOI: 10.3390/ijms24043552.


References
1.
Chava S, Reynolds C, Pathania A, Gorantla S, Poluektova L, Coulter D . miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Mol Oncol. 2019; 14(1):180-196. PMC: 6944109. DOI: 10.1002/1878-0261.12588. View

2.
Zhang Q, Zhang Q, Jiang X, Ye Y, Liao H, Zhu F . Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN. Theranostics. 2019; 9(4):986-1000. PMC: 6401405. DOI: 10.7150/thno.30199. View

3.
Li X, Li B, Ran P, Wang L . Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma. Oncol Lett. 2018; 16(5):5697-5708. PMC: 6176255. DOI: 10.3892/ol.2018.9336. View

4.
Zhao X, Li D, Yang F, Lian H, Wang J, Wang X . Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5. Mol Ther. 2020; 28(3):946-962. PMC: 7054727. DOI: 10.1016/j.ymthe.2019.12.013. View

5.
Zhang H, Wang F, Wang Y, Zhao Z, Qiao P . lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback regulatory loop with the miR‑34a/mTOR/SIRT1 pathway in colorectal cancer. Oncol Rep. 2021; 45(1):202-216. PMC: 7709827. DOI: 10.3892/or.2020.7825. View